Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Mechanisms of Cardiorenal Protection With SGLT2 Inhibitors in Patients With T2DM Based on Network Pharmacology
Anzhu Wang, Zhendong Li, Zhuo Sun, et al.
Frontiers in Cardiovascular Medicine (2022) Vol. 9
Open Access | Times Cited: 10

Showing 10 citing articles:

New Insight in Cardiorenal Syndrome: From Biomarkers to Therapy
Giovanna Gallo, Oreste Lanza, Carmine Savoia
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 6, pp. 5089-5089
Open Access | Times Cited: 26
SGLT2 Inhibitors and How They Work Beyond the Glucosuric Effect. State of the Art
David Aristizábal-Colorado, Martín Ocampo Posada, Wilfredo Antonio Rivera Martínez, et al.
American Journal of Cardiovascular Drugs (2024) Vol. 24, Iss. 6, pp. 707-718
Closed Access | Times Cited: 5
Mitochondrial Changes Induced by SGLT2i in Lymphocytes from Diabetic Kidney Transplant Recipients: A Pilot Study
Isabel Pérez-Flores, Andrea R. López‐Pastor, Ulises Gómez-Pinedo, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 7, pp. 3351-3351
Open Access
Cardiovascular outcomes and molecular targets for the cardiac effects of Sodium-Glucose Cotransporter 2 Inhibitors: A systematic review
Rosalinda Madonna, Filippo Biondi, Mattia Alberti, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 175, pp. 116650-116650
Open Access | Times Cited: 4
An Overview of the Effects of Sodium-Glucose Cotransporter-2 Inhibitors on Hematological Parameters in Diabetic Patients
Ghada Ahmed, Mohammed N. Abed, Fawaz A. Alassaf
˜Al-œMağallaẗ al-ʻirāqiyyaẗ li-l-ṣaydalaẗ (2023) Vol. 20, Iss. 1, pp. 65-71
Open Access | Times Cited: 9
Personalized Management for Heart Failure with Preserved Ejection Fraction
Chang-Yi Lin, Heng-You Sung, Ying‐Ju Chen, et al.
Journal of Personalized Medicine (2023) Vol. 13, Iss. 5, pp. 746-746
Open Access | Times Cited: 6
Alterations in trimethylamine-N-oxide in response to Empagliflozin therapy: a secondary analysis of the EMMY trial
Faisal Aziz, Norbert J. Tripolt, Peter N. Pferschy, et al.
Cardiovascular Diabetology (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 5
Angiotensin II reduces glyoxalase 1 activity and expression in vascular smooth muscle cells: Implications for diabetic vascular complications
Mustafa Kırça, Akın Yeşilkaya
Cell Biochemistry and Function (2023) Vol. 41, Iss. 8, pp. 1430-1441
Closed Access | Times Cited: 3
Network pharmacology and molecular docking study of Ermiaosan (二妙散) in the treatment of ulcerative colitis with dampness-heat syndrome
Ying Qu, Shiying Li, Weiming Wu, et al.
Deleted Journal (2024) Vol. 6, Iss. 2
Open Access
Hypoglycemic Activity of Rice Resistant-Starch Metabolites: A Mechanistic Network Pharmacology and In Vitro Approach
Jianing Ren, Jing Dai, Yue Chen, et al.
Metabolites (2024) Vol. 14, Iss. 4, pp. 224-224
Open Access
Inhibition of the RXRA-PPARα-FABP4 signaling pathway alleviates vascular cellular aging by an SGLT2 inhibitor in an atherosclerotic mice model
Weiwei Zhang, Linghuan Wang, Yujia Wang, et al.
Science China Life Sciences (2024)
Closed Access
Page 1

Scroll to top